First Trust Advisors LP bought a new stake in Orthofix International NV (NASDAQ:OFIX) during the second quarter, Holdings Channel reports. The fund bought 32,202 shares of the medical device company’s stock, valued at approximately $1,365,000. First Trust Advisors LP owned 0.18% of Orthofix International NV as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of Orthofix International NV during the fourth quarter valued at about $9,643,000. Renaissance Technologies LLC raised its stake in shares of Orthofix International NV by 78.7% in the first quarter. Renaissance Technologies LLC now owns 456,379 shares of the medical device company’s stock valued at $18,949,000 after buying an additional 201,020 shares during the period. Acadian Asset Management LLC raised its stake in shares of Orthofix International NV by 25.1% in the second quarter. Acadian Asset Management LLC now owns 660,196 shares of the medical device company’s stock valued at $27,993,000 after buying an additional 132,537 shares during the period. Emerald Acquisition Ltd. acquired a new stake in shares of Orthofix International NV during the second quarter valued at about $4,435,000. Finally, GSA Capital Partners LLP raised its stake in shares of Orthofix International NV by 66.2% in the second quarter. GSA Capital Partners LLP now owns 82,612 shares of the medical device company’s stock valued at $3,503,000 after buying an additional 32,920 shares during the period. 91.26% of the stock is owned by institutional investors and hedge funds.
Shares of Orthofix International NV (NASDAQ:OFIX) traded up 2.23% during trading on Friday, reaching $43.07. 72,412 shares of the company’s stock traded hands. The company has a 50 day moving average price of $43.91 and a 200-day moving average price of $43.76. Orthofix International NV has a one year low of $32.25 and a one year high of $48.25. The stock’s market cap is $780.60 million.
Orthofix International NV (NASDAQ:OFIX) last released its quarterly earnings results on Monday, August 1st. The medical device company reported $0.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.08. The business earned $104.10 million during the quarter, compared to analyst estimates of $102.40 million. Orthofix International NV had a negative net margin of 0.37% and a positive return on equity of 8.50%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.36 earnings per share. On average, equities research analysts expect that Orthofix International NV will post $1.41 EPS for the current fiscal year.
Several brokerages recently issued reports on OFIX. TheStreet lowered shares of Orthofix International NV from a “buy” rating to a “hold” rating in a research report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Orthofix International NV from a “hold” rating to a “strong-buy” rating and set a $49.00 target price for the company in a research report on Thursday, August 4th.
In related news, insider Michael Finegan sold 25,000 shares of the stock in a transaction that occurred on Thursday, September 1st. The shares were sold at an average price of $45.16, for a total value of $1,129,000.00. Following the completion of the transaction, the insider now directly owns 51,670 shares of the company’s stock, valued at approximately $2,333,417.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 5.10% of the company’s stock.
About Orthofix International NV
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International NV (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International NV and related companies with MarketBeat.com's FREE daily email newsletter.